CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report)’s stock price shot up 9.9% on Friday . The stock traded as high as C$5.10 and last traded at C$5.10. Approximately 360 shares changed hands during trading, a decline of 89% from the average daily volume of 3,179 shares. The stock had previously closed at C$4.64.
CSPC Pharmaceutical Group Trading Up 9.9%
The stock’s fifty day moving average is C$4.30 and its 200-day moving average is C$4.30.
CSPC Pharmaceutical Group Company Profile
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.
Featured Articles
- Five stocks we like better than CSPC Pharmaceutical Group
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
